News for Aptiv PLC (0YCP.L)

Aptiv PLC (APTV) closed at $70.46 in the latest trading session, marking a -2.02% move from the prior day.

APTIV HLDS LTD (APTV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Aptiv is scheduled to report its second-quarter results later this month, and analysts are projecting a double-digit rise in earnings.

In the latest trading session, Aptiv PLC (APTV) closed at $68.2, marking a -2.95% move from the previous day.

On July 16, 2025, Barclays analyst Dan Levy made notable adjustments to the stock outlook for Aptiv (APTV). The price target for APTV has been raised from $65.0

Barclays analyst Dan Levy has increased the target price for Aptiv (APTV) stock from $65 to $85, while maintaining an Equal Weight rating. The firm has offered

APTIV HLDS LTD (APTV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

On July 14, 2025, UBS analyst Joseph Spak maintained a 'Neutral' rating for Aptiv (APTV) while raising the price target from $66.00 to $75.00. This change refle

UBS analyst Joseph Spak has adjusted the price target for Aptiv (APTV), raising it from $66 to $75 while maintaining a Neutral rating on the stock. Spak anticip

Aptiv PLC (APTV) reached $69.28 at the closing of the latest trading day, reflecting a -1.84% change compared to its last close.

On July 11, 2025, analyst David Leiker from Baird released a report regarding Aptiv (APTV), in which the firm maintained its "Outperform" rating on the stock. T

Baird has increased its price target for Aptiv (APTV) shares to $82 from $80, maintaining a positive outlook on the stock. Analyst Luke Junk expressed greater o

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Joseph L. (Jay) Hooley to the Company's

IDEXX Laboratories (IDXX) has appointed Joseph L. (Jay) Hooley to its Board of Directors, effective July 10, 2025. Jay Hooley brings extensive strategic

RBC Capital's analyst, Tom Narayan, has increased the price target for Aptiv (APTV) shares from $77 to $85, maintaining an Outperform rating. This adjustment co

Aptiv PLC (APTV) has recently been in the spotlight, drawing interest from investors and financial analysts due to its robust financial stance. With shares curr

APTIV HLDS LTD (APTV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.